替加环素联合头孢哌酮舒巴坦治疗多重耐药鲍曼不动杆菌肺部感染临床评价OACSTPCD
Clinical Evaluation of Tigecycline Combined with Sulbactam and Cefopcrazone in Treating Lung Infection due to Multidrug-Resistant Acinetobacter Baumannii
目的 探讨替加环素联合头孢哌酮舒巴坦治疗多重耐药鲍曼不动杆菌肺部感染的临床疗效.方法 选取医院2015年9月至2016年9月收治的多重耐药鲍曼不动杆菌肺部感染患者82例,按随机数字表法分为两组,各41例.对照组患者采用头孢哌酮舒巴坦治疗,观察组患者在对照组基础上加用替加环素治疗.结果 观察组患者治疗总有效率为95.12％,高于对照组的78.05％(P<0.05);细菌清除率为58.54％,高于对照组的34.15％(P<0.05);两组…查看全部>>
Objective To investigate the clinical efficacy of tigecycline combined with sulbactam and cefopcrazone in the treatment of lung infection due to multidrug-resistant Acinetobacter baumannii ( MDR-AB ) . Methods Totally 82 patients with lung infection due to MDR-AB admitted to our hospital from September 2015 to September 2016 were divided into two groups according to the random number table method, 41 cases in each group. The control group was treated with su…查看全部>>
罗青林;刘勇;柏合;赵龙
牡丹江医学院附属红旗医院,黑龙江牡丹江 157011牡丹江医学院医药研究中心,黑龙江牡丹江 157011牡丹江医学院医药研究中心,黑龙江牡丹江 157011牡丹江医学院附属红旗医院,黑龙江牡丹江 157011
医药卫生
替加环素头孢哌酮舒巴坦多重耐药鲍曼不动杆菌肺部感染
tigecyclinesulbactam and cefopcrazonemultidrug-resistant Acinetobacter baumanniilung infection
《中国药业》 2017 (17)
34-36,3
评论